Adjuvant methotrexate, vinblastine and cisplatin chemotherapy for invasive transitional cell carcinoma: Taiwan experience

Journal of Urology

Volumn 155, Issue 1, 1996, Pages 118-121

  Wei, Chih Hsin ^a   Hsieh, Ruey Kuen ^a,b   Chiou, Tzeon Jye ^a   Chen, Kuang Kuo ^a   Chang, Luke S ^a   Chen, Po Min ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Carcinoma, transitional cell; Cisplatin; Drug therapy; Methotrexate; Vinblastine

Indexed keywords

CISPLATIN; METHOTREXATE; VINBLASTINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; HIGH RISK PATIENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CARCINOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLADDER NEOPLASMS; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMAN; KIDNEY NEOPLASMS; MALE; METHOTREXATE; MIDDLE AGE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; TIME FACTORS; URETERAL NEOPLASMS; VINBLASTINE;

EID: 0029656186     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66564-9     Document Type: Article

References (16)

1. Skinner, D. G. and Lieskovsky, G.: Management of invasive and high-grade bladder cancer. In: Diagnosis and Management of Genitourinary Cancer. Philadelphia: W. B. Saunders Co., chapt. 16, pp. 295-313, 1988.
2. Skinner, D. G. and Lieskovsky, G.: Technique of radical cystectomy. In: Diagnosis and Management of Genitourinary Cancer. Philadelphia: W. B. Saunders Co., chapt. 42, pp. 607-622, 1988.
3. Skinner, D. G.: Current perspectives in the management of high-grade invasive bladder cancer. Cancer, suppl. 7, 45: 1866, 1980.
4. Scher, H. I. and Norton, L.: Chemotherapy for urothelial tract malignancies: breaking the deadlock. Sem. Surg. Oncol., 8: 316, 1992.
5. Sternberg, C. N., Yagoda, A., Scher, H. I., Watson, R. C., Ahmed, T., Weiselberg, L. R., Geller, N., Hollander, P. S., Herr, H. W., Sogani, P. C., Morse, M. J. and Whitmore, W. F.: Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J. Urol., 133: 403, 1985.
6. Harker, W. G., Meyers, F. J., Freiha, F. S., Palmer, J. M., Shortliffe, L. D., Hannigan, J. F., McWhirter, K. M. and Torti, F. M.: Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study. J. Clin. Oncol., 3: 1463, 1985.
7. Sternberg, C. N., Yagoda, A., Scher, H. I., Watson, R. C., Herr, H. W., Morse, M. J., Sogani, P. C., Vaughan, E. D., Jr., Bander, N., Weiselberg, L. R., Geller, N., Hollander, P. S., Lipperman, R., Fair, W. R. and Whitmore, W. F., Jr.: M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J. Urol., 139: 461, 1988.
8. Loehrer, P. J., Sr., Einhorn, L. H., Elson, P. J., Crawford, E. D., Kuebler, P., Tannock, I., Raghavan, D., Stuart-Harris, R., Sarosdy, M. F., Lowe, B. A., Blumenstein, B. and Trump, D.: A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J. Clin. Oncol., 10: 1066, 1992.
9. Tannock, I. F., Gospodarowicz, M. and Evans, W. K.: Chemotherapy for metastatic transitional carcinoma of the urinary tract. A prospective trial of methotrexate, adriamycin, and cyclophosphamide (MAC) with cis-platinum for failure. Cancer, 51: 216, 1983.
10. Tannock, I., Gospodarowicz, M., Connolly, J. and Jewett, M.: M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for transitional cell carcinoma: the Princess Margaret Hospital experience. J. Urol., 142: 289, 1989.
11. Frazier, H. A., Robertson, J. E., Dodge, R. K. and Paulson, D. F.: The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer, 71: 3993, 1993.
12. Beahrs, O. H.: American Joint Committee on Cancer: Manual for Staging of Cancer, 3rd ed. Philadelphia: J. B. Lippincott Co., p. 194, 1988.
13. Miller, A. B., Hoogstraten, B., Staquet, M. and Winkler, A.: Reporting results of cancer treatment. Cancer, 47: 207, 1981.
14. Kaplan, E. L. and Meier, P.: Nonparametric estimation from incomplete observations. J. Amer. Stat. Ass., 53: 457, 1958.
15. Skinner, D. G., Daniels, J. R., Russell, C. A., Lieskovsky, G., Boyd, S. D., Nichols, P., Kern, W., Sakamoto, J., Krailo, M. and Groshen, S.: The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J. Urol., 145: 459, 1991.
16. Logothetis, C. J., Johnson, D. E., Chong, C., Dexeus, F. H., Sella, A., Ogden, S., Smith, T., Swanson, D. A., Babaian, R. J., Wishnow, K. I. and von Eschenbach, A. C.: Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update. J. Clin. Oncol., 6: 1590, 1988.